Melanoma Journal Articles for November 2019
BMC Cancer
Severe colitis after PD-1 blockade with nivolumab in advanced melanoma patients: potential role of Th1-dominant immune response in immune-related adverse events: two case reports
Koji Yoshino, Takayuki Nakayama, Ayumu Ito, Eiichi Sato & Shigehisa Kitano
BMC Cancer volume 19, Article number: 1019 (2019)
Cancer Research
Vitamin D-VDR signaling inhibits Wnt/beta-catenin-mediated melanoma progression and promotes anti-tumor immunity
Sathya Muralidhar, Anastasia Filia, Jérémie Nsengimana, Joanna Po?niak, Sally J. O’Shea, Joey M Diaz, Mark Harland, Juliette A. Randerson-Moor, Jörg Reichrath, Jonathan P Laye, Louise van der Weyden, David J. Adams, D.T. Bishop and Julia Newton-Bishop
DOI: 10.1158/0008-5472.CAN-18-3927
Clinical Cancer Research
Transcriptomic Analysis Reveals Prognostic Molecular Signatures of Stage I Melanoma
Rohit Thakur, Jonathan P. Laye, Martin Lauss, Joey Mark S. Diaz, Sally Jane O’Shea, Joanna Po?niak, Anastasia Filia, Mark Harland, Joanne Gascoyne, Juliette A. Randerson-Moor, May Chan, Tracey Mell, Göran Jönsson, D. Timothy Bishop, Julia Newton-Bishop, Jennifer H. Barrett and Jérémie Nsengimana
DOI: 10.1158/1078-0432.CCR-18-3659
Cureus
Concurrent Radiosurgery and Systemic Therapies for Melanoma Brain Metastases: A Systematic Review
Bradley D. Weaver, James R. Goodman, Randy Jensen
Published: November 13, 2019 (see history)
DOI: 10.7759/cureus.6147
Nature Communications
Targeting melanoma’s MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors
Matthew J. Sale, Emma Minihane, Noel R. Monks, Rebecca Gilley, Frances M. Richards, Kevin P. Schifferli, Courtney L. Andersen, Emma J. Davies, Mario Aladren Vicente, Eiko Ozono, Aleksandra Markovets, Jonathan R. Dry, Lisa Drew, Vikki Flemington, Theresa Proia, Duncan I. Jodrell, Paul D. Smith & Simon J. Cook
Nature Communications volume 10, Article number: 5167 (2019)
doi:10.1038/s41467-019-12409-w
Dove Press
miR-124 Functions As A Melanoma Tumor Suppressor By Targeting RACK1
Authors Shen C, Hua H, Gu L, Cao S, Cai H, Yao X, Chen X
Received 28 July 2019
Accepted for publication 31 October 2019
Published 19 November 2019 Volume 2019:12 Pages 9975—9986
DOI https://doi.org/10.2147/OTT.S225120
Molecular Cancer Therapeutics
Cancer Biology and Translational Studies
Distinct Transcriptional Programming Drive Response to MAPK Inhibition in BRAFV600-Mutant Melanoma Patient-Derived Xenografts
Tianshu Feng, Javad Golji, Ailing Li, Xiamei Zhang, David A. Ruddy, Daniel P. Rakiec, Felipe C. Geyer, Jane Gu, Hui Gao, Juliet A. Williams, Darrin D. Stuart and Matthew J. Meyer
DOI: 10.1158/1535-7163.MCT-19-0028
Journal of Cell Science
Melanoma mutations modify melanocyte dynamics in coculture with keratinocytes or fibroblasts
Dubravka Škalamera, Alexander J. Stevenson, Anna Ehmann, Stephen A. Ainger, Catherine Lanagan, Richard A. Sturm, Brian Gabrielli
Journal of Cell Science 2019 : jcs.234716 doi: 10.1242/jcs.234716 Published 25 November 2019
British Journal of Dermatology
Epidemiology
Clinicopathological factors associated with death from thin (? 1·00 mm) melanoma
First published: 28 September 2019 https://doi.org/10.1111/bjd.18560
BMC Women’s Health
Primary malignant melanoma arising from ruptured ovarian mature cystic teratoma with elevated serum CA 19–9: a case report and review of literature
Won Ku Choi, Dong Hyun Lee, Dong Hyu Cho, Kyu Yun Jang & Kyoung Min Kim
BMC Women’s Health volume 19, Article number: 149 (2019)
BMC Journal for ImmunoTherapy of Cancer
Ginseng-derived nanoparticles alter macrophage polarization to inhibit melanoma growth
Meng Cao, Huaijiang Yan, Xuan Han, Ling Weng, Qin Wei, Xiaoyan Sun, Wuguang Lu, Qingyun Wei, Juan Ye, Xueting Cai, Chunping Hu, Xiaoyang Yin & Peng Cao
Journal for ImmunoTherapy of Cancer volume 7, Article number: 326 (2019)
BMC Journal for ImmunoTherapy of Cancer
TLR9 activation cooperates with T cell checkpoint blockade to regress poorly immunogenic melanoma
Matthew J. Reilley, Brittany Morrow, Casey R. Ager, Arthur Liu, David S. Hong & Michael A. Curran
Journal for ImmunoTherapy of Cancer volume 7, Article number: 323 (2019)